Inhibition of lymphangiogenic factor VEGF-C expression and production by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in breast cancer cells

By    

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 1238-1244

Spandidos Publications

Access to resources Recommend Favorite

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer

By Shi Yi-kang   Li Zhong-hua   Han Xi-qian   Yi Ji-hu   Wang Zhen-hua   Hou Jing-li   Feng Cong-ran   Fang Qing-hong   Wang Hui-hui   Zhang Peng-fei   Wang Feng-shan   Shen Jie   Wang Peng  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1131-1140

Springer Publishing Company

Access to resources Recommend Favorite

Histone deacetylase inhibitor suberoyl bis-hydroxamic acid suppresses cell proliferation and induces apoptosis in breast cancer cells

By          

Molecular Medicine Reports, Vol. 11, Iss. 4, 2015-01 ,pp. : 2908-2912

Spandidos Publications

Access to resources Recommend Favorite

Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S 2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients

By Hsieh Yi-Hsuan  

Carcinogenesis, Vol. 34, Iss. 2, 2013-02 ,pp. : 475-485

Oxford University Press

Access to resources Recommend Favorite

Synergistic effects of suberoylanilide hydroxamic acid combined with cisplatin causing cell cycle arrest independent apoptosis in platinum-resistant ovarian cancer cells

By Ong Pei-Shi   Wang Xin-Qiao   Lin Hai-Shu   Chan Sui-Yung   Ho Paul C.  

International Journal of Oncology, Vol. 40, Iss. 5, 2012-05 ,pp. : 1705-1713

Spandidos Publications

Access to resources Recommend Favorite